Dingqiao Xu
Jiangsu Key Laboratory Of Bioactive Natural Product Research And State Key Laboratory Of Natural Medicines, 24 Tong Jia Xiang
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NMR-based metabolomics approach reveals effects of antioxidant nutrients in sepsis-induced changes in rat liver injury.
Journal: The Journal of nutritional biochemistry
Published: September 18, 2019
1H NMR-Based Metabolomics Reveals Refined-Huang-Lian-Jie-Du-Decoction (BBG) as a Potential Ischemic Stroke Treatment Drug With Efficacy and a Favorable Therapeutic Window.
Journal: Frontiers in pharmacology
Published: December 08, 2018
Metabolomics Coupled with Transcriptomics Approach Deciphering Age Relevance in Sepsis.
Journal: Aging and disease
Published: September 12, 2018
Metal ion-improved complexation countercurrent chromatography for enantioseparation of dihydroflavone enantiomers.
Journal: Journal of chromatography. A
Published: September 16, 2017
Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis.
Journal: Bioorganic chemistry
Published: August 11, 2017
Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi.
Journal: Analytica chimica acta
Published: July 02, 2017
Optimization of Huang-Lian-Jie-Du-Decoction for Ischemic Stroke Treatment and Mechanistic Study by Metabolomic Profiling and Network Analysis.
Journal: Frontiers in pharmacology
Published: December 25, 2016
Deciphering the mechanism of Huang-Lian-Jie-Du-Decoction on the treatment of sepsis by formula decomposition and metabolomics: Enhancement of cholinergic pathways and inhibition of HMGB-1/TLR4/NF-κB signaling.
Journal: Pharmacological research
Published: December 14, 2016
Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Journal: Scientific reports
Published: October 31, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026